Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei

Burkholderia pseudomallei is the causative agent of melioidosis, a serious disease endemic in Southeast Asia and Northern Australia. Antibiotic treatment is lengthy and relapse often occurs. Finafloxacin is a novel fluoroquinolone with increased antibacterial activity in acidic conditions in contras...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487660/
https://www.ncbi.nlm.nih.gov/pubmed/28438936
http://dx.doi.org/10.1128/AAC.00082-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487660/
https://www.ncbi.nlm.nih.gov/pubmed/28438936
http://dx.doi.org/10.1128/AAC.00082-17

Ejemplares similares